WASHINGTON—Officials should consider women’s reports of pain, sexual dysfunction and other maladies as they re-evaluate a medical device used in women’s pelvic surgery that has triggered thousands of lawsuits, an advisory panel said.
The panel of outside doctors, convened to advise the Food and Drug Administration, recommended that the agency evaluate women’s medical self-reports as it decides whether synthetic mesh products should stay on the market. Such recommendations are generally, but not always, followed by the federal...
Read More